Tealwood Asset Management Inc Novartis Ag Transaction History

Tealwood Asset Management Inc

$242 Million
Q4 2024

A detailed history of Tealwood Asset Management Inc transactions in Novartis Ag stock. As of the latest transaction made, Tealwood Asset Management Inc holds 24,249 shares of NVS stock, worth $2.71 Million. This represents 0.98% of its overall portfolio holdings.

Number of Shares

24,249

Previous 23,918 1.38%

Holding current value

$2.71 Million

Previous $2.75 Million 14.21%

% of portfolio

0.98%

Previous 1.2%

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Jan 13, 2025	BUY	$96.78 - $117.18 $32,034 - $38,786	331 Added 1.38%	24,249 $2.36 Million
Q3 2024 Oct 08, 2024	SELL	$106.13 - $120.89 $32,051 - $36,508	-302 Reduced 1.25%	23,918 $2.75 Million
Q2 2024 Jul 09, 2024	SELL	$92.57 - $107.37 $21,198 - $24,587	-229 Reduced 0.94%	24,220 $2.58 Million
Q1 2024 Apr 11, 2024	BUY	$95.27 - $108.47 $11,718 - $13,341	123 Added 0.51%	24,449 $2.37 Million
Q4 2023 Jan 08, 2024	SELL	$92.27 - $101.54 $34,139 - $37,569	-370 Reduced 1.5%	24,326 $2.46 Million
Q3 2023 Nov 08, 2023	SELL	$94.73 - $105.13 $15,156 - $16,820	-160 Reduced 0.64%	24,696 $2.52 Million
Q2 2023 Jul 26, 2023	SELL	$92.52 - $104.91 $32,844 - $37,243	-355 Reduced 1.41%	24,856 $2.51 Million
Q1 2023 Apr 12, 2023	SELL	$80.03 - $92.81 $17,766 - $20,603	-222 Reduced 0.87%	25,211 $2.32 Million
Q4 2022 Jan 17, 2023	SELL	$75.55 - $92.52 $67,919 - $83,175	-899 Reduced 3.41%	25,433 $2.31 Million
Q3 2022 Nov 16, 2022	SELL	$74.61 - $87.26 $15,742 - $18,411	-211 Reduced 0.79%	26,332 $2 Million
Q2 2022 Jul 20, 2022	BUY	$80.52 - $93.75 $2.14 Million - $2.49 Million	26,543 New	26,543 $2.24 Million

Others Institutions Holding NVS

# of Institutions

1,478

Shares Held

134M

Call Options Held

1.31M

Put Options Held

1.56M

View Full List

About NOVARTIS AG

Ticker NVS
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,151,000,064
Market Cap $240B
Description
Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...

More about NVS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Tealwood Asset Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Tealwood Asset Management Inc with notifications on news.

Account

Tealwood Asset Management Inc Novartis Ag Transaction History